Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Endothelial AHR activity prevents lung barrier disruption in viral infection

Abstract

Disruption of the lung endothelial–epithelial cell barrier following respiratory virus infection causes cell and fluid accumulation in the air spaces and compromises vital gas exchange function1. Endothelial dysfunction can exacerbate tissue damage2,3, yet it is unclear whether the lung endothelium promotes host resistance against viral pathogens. Here we show that the environmental sensor aryl hydrocarbon receptor (AHR) is highly active in lung endothelial cells and protects against influenza-induced lung vascular leakage. Loss of AHR in endothelia exacerbates lung damage and promotes the infiltration of red blood cells and leukocytes into alveolar air spaces. Moreover, barrier protection is compromised and host susceptibility to secondary bacterial infections is increased when endothelial AHR is missing. AHR engages tissue-protective transcriptional networks in endothelia, including the vasoactive apelin–APJ peptide system4, to prevent a dysplastic and apoptotic response in airway epithelial cells. Finally, we show that protective AHR signalling in lung endothelial cells is dampened by the infection itself. Maintenance of protective AHR function requires a diet enriched in naturally occurring AHR ligands, which activate disease tolerance pathways in lung endothelia to prevent tissue damage. Our findings demonstrate the importance of endothelial function in lung barrier immunity. We identify a gut–lung axis that affects lung damage following encounters with viral pathogens, linking dietary composition and intake to host fitness and inter-individual variations in disease outcome.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: The endothelium is a site of increased AHR activity in the lung.
Fig. 2: AHR signalling in endothelia prevents lung vascular leakage after viral infection.
Fig. 3: Endothelial AHR mediates lung protection through apelin signalling and prevents a dysplastic apoptotic response in airway epithelia.
Fig. 4: Loss of protective lung AHR signalling after influenza virus infection is regulated by dietary intake.

Similar content being viewed by others

Data availability

Sequencing data are available in the Gene Expression Omnibus under accession codes GSE203427 and GSE225958Source data are provided with this paper.

References

  1. Matthay, M. A et al. Acute respiratory distress syndrome. Nat. Rev. Dis. Primers 5, 18 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Bonaventura, A. et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat. Rev. Immunol. 21, 319–329 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Teijaro, J. R. et al. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 146, 980–991 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Kleinz, M. J., Skepper, J. N. & Davenport, A. P. Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells. Regul. Pept. 126, 233–240 (2005).

    Article  CAS  PubMed  Google Scholar 

  5. Krausgruber, T. et al. Structural cells are key regulators of organ-specific immune responses. Nature 583, 296–302 (2020).

    Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

  6. Hogan, B. L. M. et al. Repair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell function. Cell Stem Cell 15, 123–138 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Fernanda de Mello Costa, M., Weiner, A. I. & Vaughan, A. E. Basal-like progenitor cells: a review of dysplastic alveolar regeneration and remodeling in lung repair. Stem Cell Rep. 15, 1015–1025 (2020).

    Article  CAS  Google Scholar 

  8. Basil, M. C. et al. The cellular and physiological basis for lung repair and regeneration: past, present, and future. Cell Stem Cell 26, 482–502 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Zhao, G. et al. Regeneration of the pulmonary vascular endothelium after viral pneumonia requires COUP-TF2. Sci. Adv. 6, eabc4493 (2020).

    Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

  10. Niethamer, T. K. et al. Defining the role of pulmonary endothelial cell heterogeneity in the response to acute lung injury. eLife 9, e53072 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Ding, B. Sen et al. Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization. Cell 147, 539–553 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Lee, J. H. et al. Lung stem cell differentiation in mice directed by endothelial cells via a BMP4–NFATc1–thrombospondin-1 axis. Cell 156, 440–455 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Rafii, S. et al. Platelet-derived SDF-1 primes the pulmonary capillary vascular niche to drive lung alveolar regeneration. Nat. Cell Biol. 17, 123–136 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Stockinger, B., Di Meglio, P., Gialitakis, M. & Duarte, J. H. The aryl hydrocarbon receptor: multitasking in the immune system. Annu. Rev. Immunol. 32, 403–432 (2014).

    Article  CAS  PubMed  Google Scholar 

  15. Denison, M. S. & Nagy, S. R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43, 309–334 (2003).

    Article  CAS  PubMed  Google Scholar 

  16. Wincent, E. et al. Inhibition of cytochrome P4501-dependent clearance of the endogenous agonist FICZ as a mechanism for activation of the aryl hydrocarbon receptor. Proc. Natl Acad. Sci. USA 109, 4479–4484 (2012).

    Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

  17. Chiaro, C. R., Patel, R. D., Marcus, C. B. & Perdew, G. H. Evidence for an aryl hydrocarbon receptor-mediated cytochrome P450 autoregulatory pathway. Mol. Pharmacol. 72, 1369–1379 (2007).

    Article  CAS  PubMed  Google Scholar 

  18. Li, Y. et al. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 147, 629–640 (2011).

    Article  CAS  PubMed  Google Scholar 

  19. Kiss, E. A. et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 334, 1561–1565 (2011).

    Article  CAS  PubMed  ADS  Google Scholar 

  20. Qiu, J. et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36, 92–104 (2012).

    Article  CAS  PubMed  Google Scholar 

  21. Schiering, C. et al. Feedback control of AHR signalling regulates intestinal immunity. Nature 542, 242–245 (2017).

    Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

  22. Metidji, A. et al. The environmental sensor AHR protects from inflammatory damage by maintaining intestinal stem cell homeostasis and barrier integrity. Immunity https://doi.org/10.1016/j.immuni.2018.07.010 (2018).

  23. Stockinger, B., Shah, K. & Wincent, E. AHR in the intestinal microenvironment: safeguarding barrier function. Nat. Rev. Gastroenterol. Hepatol. 18, 559–570 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Gronke, K. et al. Interleukin-22 protects intestinal stem cells against genotoxic stress. Nature https://doi.org/10.1038/s41586-019-0899-7 (2019).

  25. Yamada, T. et al. Constitutive aryl hydrocarbon receptor signaling constrains type I interferon-mediated antiviral innate defense. Nat. Immunol. 17, 687–694 (2016).

    Article  CAS  PubMed  Google Scholar 

  26. Villa, M. et al. The aryl hydrocarbon receptor controls cyclin O to promote epithelial multiciliogenesis. Nat. Commun. 7, 12652 (2016).

    Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

  27. Moura-Alves, P. et al. AhR sensing of bacterial pigments regulates antibacterial defence. Nature 512, 387–392 (2014).

    Article  CAS  PubMed  ADS  Google Scholar 

  28. Diny, N. L. et al. The aryl hydrocarbon receptor contributes to tissue adaptation of intestinal eosinophils in mice. J. Exp. Med. 219, e20210970 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Henderson, C. J. et al. Application of a novel regulatable Cre recombinase system to define the role of liver and gut metabolism in drug oral bioavailability. Biochem. J. 465, 479–488 (2015).

    Article  CAS  PubMed  Google Scholar 

  30. Schupp, J. C. et al. Integrated single-cell atlas of endothelial cells of the human lung. Circulation 144, 286–302 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Dragin, N. et al. Phenotype of the Cyp1a1/1a2/1b1(–/–) triple-knockout mouse. Mol. Pharmacol. 73, 1844–1856 (2008).

    Article  CAS  PubMed  Google Scholar 

  32. Medzhitov, R., Schneider, D. S. & Soares, M. P. Disease tolerance as a defense strategy. Science 335, 936–942 (2012).

    Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

  33. Shimada, T. et al. Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice. Carcinogenesis 23, 1199–1207 (2002).

    Article  CAS  PubMed  Google Scholar 

  34. Kumar, P. A. et al. Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell 147, 525–538 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Vaughan, A. E. et al. Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury. Nature 517, 621–625 (2015).

    Article  CAS  PubMed  ADS  Google Scholar 

  36. Zuo, W. et al. p63+Krt5+ distal airway stem cells are essential for lung regeneration. Nature 517, 616–620 (2014).

    Article  PubMed  PubMed Central  ADS  Google Scholar 

  37. Quantius, J. et al. Influenza virus infects epithelial stem/progenitor cells of the distal lung: impact on Fgfr2b-driven epithelial repair. PLoS Pathog. 12, e1005544 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  38. McQualter, J. L., Yuen, K., Williams, B. & Bertoncello, I. Evidence of an epithelial stem/progenitor cell hierarchy in the adult mouse lung. Proc. Natl Acad. Sci. USA 107, 1414–1419 (2010).

    Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

  39. Cox, C. M., D’Agostino, S. L., Miller, M. K., Heimark, R. L. & Krieg, P. A. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev. Biol. 296, 177–189 (2006).

    Article  CAS  PubMed  Google Scholar 

  40. Gillich, A. et al. Capillary cell-type specialization in the alveolus. Nature 586, 785–789 (2020).

    Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

  41. He, Q. et al. Apelin-36 protects against lipopolysaccharide-induced acute lung injury by inhibiting the ASK1/MAPK signaling pathway. Mol. Med. Rep. 23, 6 (2021).

  42. Kong, X. et al. Apelin-13-Mediated AMPK ameliorates endothelial barrier dysfunction in acute lung injury mice via improvement of mitochondrial function and autophagy. Int. Immunopharmacol. 101, 108230 (2021).

  43. Fan, X. F. et al. The apelin–APJ axis is an endogenous counterinjury mechanism in experimental acute lung injury. Chest 147, 969–978 (2015).

    Article  PubMed  Google Scholar 

  44. Macaluso, N. J. M., Pitkin, S. L., Maguire, J. J., Davenport, A. P. & Glen, R. C. Discovery of a competitive apelin receptor (APJ) antagonist. ChemMedChem 6, 1017–1023 (2011).

    Article  CAS  PubMed  Google Scholar 

  45. Bjeldanes, L. F., Kim, J. Y., Grose, K. R., Bartholomew, J. C. & Bradfield, C. A. Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc. Natl Acad. Sci. USA 88, 9543–9547 (1991).

    Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

  46. Wiggins, B. G. et al. Endothelial sensing of AHR ligands regulates intestinal homeostasis. Nature https://doi.org/10.1038/s41586-023-06508-4 (2023).

  47. Degner, S. C., Papoutsis, A. J., Selmin, O. & Romagnolo, D. F. Targeting of aryl hydrocarbon receptor-mediated activation of cyclooxygenase-2 expression by the indole-3-carbinol metabolite 3,3′-diindolylmethane in breast cancer cells. J. Nutr. 139, 26–32 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Rothhammer, V. & Quintana, F. J. The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease. Nat. Rev. Immunol. 19, 184–197 (2019).

    Article  CAS  PubMed  Google Scholar 

  49. Lebwohl, M. G. et al. Phase 3 trials of tapinarof cream for plaque psoriasis. N. Engl. J. Med. 385, 2219–2229 (2021).

    Article  CAS  PubMed  Google Scholar 

  50. Zhu, Z. et al. Aryl hydrocarbon receptor in cutaneous vascular endothelial cells restricts psoriasis development by negatively regulating neutrophil recruitment. J. Invest. Dermatol. 140, 1233–1243.e9 (2020).

    Article  CAS  PubMed  Google Scholar 

  51. Anderton, M. J. et al. Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice. Clin. Cancer Res. 10, 5233–5241 (2004).

    Article  CAS  PubMed  ADS  Google Scholar 

  52. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).

    Article  CAS  PubMed  Google Scholar 

  53. Parrish, N., Hormozdiari, F. & Eskin, E. in Bioinformatics. The Impact of Accurate Quantification on Proteomic and Genetic Analysis and Research (ed. Liu, Y.) Ch. 2, 21–40 (Apple Academic Press, 2014).

  54. Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  55. The R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2018).

  56. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).

    Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

  57. Krämer, A., Green, J., Pollard, J. & Tugendreich, S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics 30, 523–530 (2014).

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank staff at the Crick flow cytometry, advanced sequencing, bioinformatics and animal facilities for excellent support; and J.  Kohl for help and advice on RNAscope data generation and interpretation. This work was funded by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC002085), the UK Medical Research Council (FC002085) and the Wellcome Trust (FC002085).

Author information

Authors and Affiliations

Authors

Contributions

J.M. and A.W. conceived the idea and designed the experimental strategy. J.M., S.C., K.F., B.F., R.D., M.G. and L.M. designed and performed experiments and analysed data. P.C. performed the bioinformatics analysis. K.S. and B.S. provided key intellectual input and experimental tools. A.S.-B. and S.P. performed histopathological analyses and scoring. J.M. and A.W. wrote the manuscript. All authors edited the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Jack Major or Andreas Wack.

Ethics declarations

Competing interests

The authors declare no competing interests.

Peer review

Peer review information

Nature thanks the anonymous reviewers for their contribution to the peer review of this work. Peer reviewer reports are available.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Extended data figures and tables

Extended Data Fig. 1 Gating strategies for lung cell populations.

ac, Gating strategy for lung endothelial cell and epithelial cell populations (a), RBCs and immune cells in the BALF day 6 post influenza virus infection (b), and lung lymphoid immune cell populations (c) analysed by flow cytometry.

Extended Data Fig. 2 The AHR landscape in mouse and human lung endothelia.

a, Immunofluorescence staining of steady-state AHR-tdTomato and Cyp1a1-eYFP lung sections stained with the vascular endothelial marker endomucin or lymphatic marker LYVE-1, and Hoechst (blue). Scale bars, 100 μm (left panels), 20 μm (middle panels), 5 μm (right panels). Data are representative of three independent experiments with similar results. b, Representative histogram plots of AHR-tdTomato and Cyp1a1-eYFP expression in steady-state lung endothelial cells (CD31+PDPN) and lymphatic endothelia (CD31+PDPN+) relative to B6 WT controls (grey). Mean fluorescence intensity (MFI). c, Frequency of lymphatic and vascular endothelial cells measured by flow cytometry. d, RNA-FISH analysis of WT steady-state lung. RNA probes for Ahr (cyan) and Cyp1a1 (yellow) and stained with E-Cadherin for epithelia. White arrowheads indicate Ahr expression in airway epithelial cells. Scale bar, 20 μm. Data are representative of four independent experiments with similar results. e, f, Expression of indicated genes in uniform manifold approximation and projection (UMAP) plots of mouse (e) and human (f) lung scRNA-seq datasets obtained from lungendothelialcellatlas.com. g, Primary human lung microvasculature endothelial cell (HMVEC-L) cultures were treated with AHR agonist FICZ or antagonist CH-223191 for 24 h and indicated gene expression was determined by qPCR (n = 6 biological replicates). Statistical analysis was performed using one-way ANOVA with Tukey’s post-test. Data are shown as mean±SEM. Data are shown as mean±SEM. ns, not significant.

Source data

Extended Data Fig. 3 Dampened pulmonary inflammation in CYP1-deficient mice.

a, b, Lung immune cell numbers were determined in the BALF on day 6 post infection (a) or in whole lung on indicated days post infection (b) in WT (n = 4) and Cyp1−/− (n = 5) mice by flow cytometry. c, d, BALF cytokine concentration in influenza virus infected WT and Cyp1−/− mice was determined on indicated days for IFN (n = 3) (c) or day 6 for remaining cytokines (d) post infection (n = 5). e, Histopathological analysis of WT (n = 4) and Cyp1−/− (n = 3) H&E lung sections on day 6 post infection. Black arrowheads indicate areas of perivascular, peribronchiolar, and intra-alveolar inflammatory cell infiltration. Scale bars, 500 μm (upper panels) and 100 μm (lower panels). All Data are representative of three to four independent experiments. Statistical analysis was performed using unpaired two-tailed Student’s t test (a, d), two-way ANOVA with Sidak’s post-test (b, c), or two-tailed Mann–Whitney U test (e) and significant P values are indicated on the graphs. Data are shown as mean±SEM. ns, not significant.

Source data

Extended Data Fig. 4 CYP1 deficiency confers protection against respiratory pathogens.

a, b, Lung damage was assessed in the BALF of X31 influenza virus infected WT (n = 8) and Cyp1a1/Cyp1b1 double-knockouts (Cyp1a2+/−) (n = 9) (a) or Cal09 H1N1 influenza virus infected WT (n = 6) and Cyp1−/− (n = 5) mice (b) by measurement of total cells, Ter119+ RBCs, total protein, and serum albumin concentrations on day 6 post infection. (c) Weight loss of influenza (X31) and Streptococcus pneumoniae coinfected WT (n = 23) and Cyp1−/− (n = 23) mice. All Data are representative of two independent experiments or pooled from three experiments (c). Statistical analysis was performed using unpaired two-tailed Student’s t test (a, b) or two-way ANOVA with Sidak’s post-test (c) and significant P values are indicated on the graphs. Data are shown as mean±SEM.

Source data

Extended Data Fig. 5 Endothelial-specific AHR deletion.

a, Endothelial-specific AHR deletion was determined by measuring expression of Ahr and AHR-target gene Cyp1a1 in isolated lung CD31+ endothelial cells in Cdh5Cre-ERT2Rosa26-LSL-YFP; Ahrflox/flox mice (ECΔAhr) and WT control (Cdh5Cre−Rosa26-LSL-YFP; Ahrflox/flox) mice by qPCR (n = 8) (a) or transcripts per million (TPM) from bulk RNA-seq analysis (n = 3) (b). c, YFP-expressing lung endothelial cells as a measurement of Cre induction was determined in CD31+ lung endothelial cells by flow cytometry in ECΔAhr mice (n = 5). All Data are representative of two independent experiments. Statistical analysis was performed using unpaired two-tailed Student’s t test and significant P values are indicated on the graphs. Data are shown as mean±SEM.

Source data

Extended Data Fig. 6 AHR deletion in endothelial cells does not drastically alter influenza-induced pulmonary inflammation.

a, b Immune cell numbers were determined in the BALF of WT (n = 6) and ECΔAhr (n = 5) mice (a) and whole lung (n = 4) (b) of on day 6 post infection by flow cytometry. c, BALF cytokine concentration in WT and ECΔAhr mice was determined on day 2 (IFN) or day 6 (remaining cytokines) post infection (IL-6 and IFN-λ: WT n = 6, ECΔAhr n = 8; remaining cytokines n = 4). All Data are representative of two to three independent experiments. Statistical analysis was performed using unpaired two-tailed Student’s t test and significant P values are indicated on the graphs. Data are shown as mean±SEM. ns, not significant.

Source data

Extended Data Fig. 7 AHR signalling in endothelia prevents airway epithelial apoptosis and dysplastic repair.

a, b, Heatmaps of indicated genes from bulk RNA sequencing data comparing naïve WT and ECΔAhr CD31+ lung endothelial cells (a) and EpCam+ lung epithelial cells on day 6 post infection (b) (fold change > 1.5, padj < 0.05). c, Frequency (% of total EpCam+) and proliferation (Ki67+) of distal airway stem cells (EpCamhighCD24lowMHC-II) in the lungs of WT and ECΔAhr mice was measured by flow cytometry in naïve (n = 3) mice and on day 6 post influenza infection (WT n = 6; ECΔAhr n = 5). d, Frequency of apoptotic (Annexin-V+) and necrotic (TO-PRO-3+) lung endothelial cells (CD31+), progenitor airway epithelial cells (EpCamhighCD24lowMHC-II), mature airway epithelial cells (EpCamhighCD24highMHC-II), and type II alveolar epithelial cells (EpCamlowMHC-II+) was assessed by flow cytometry in WT and ECΔAhr mice on day 6 post influenza infection (n = 4). All Data are representative of two independent experiments. Statistical analysis was performed using one-sided Wald test with Benjamini–Hochberg correction (a, b) or two-way ANOVA with Sidak’s post-test (c) and significant P values are indicated on the graphs. Data are shown as mean±SEM. ns, not significant.

Source data

Extended Data Fig. 8 AHR-dependent regulation of the apelin signalling pathway in lung endothelia.

a, Heatmap of indicated genes from RNA sequencing data comparing CD31+ lung endothelial cells on day 6 post infection (fold change > 1.5, padj < 0.05). b, Expression of indicated genes in isolated CD45+ immune cell, EpCam+ epithelial cell, and CD31+ endothelial cell was determined by qPCR in naïve WT mice (n = 4). c, d, Expression of indicated genes in UMAP plots of mouse (c) and human (d) lung scRNA-seq datasets obtained from lungendothelialcellatlas.com. e, Lung vascular leakage was assessed in PBS (n = 5) and apelin (n = 6) treated ECΔAhr mice by quantification of total cells Ter119+ RBCs in the BALF on day 6 post infection. f, Dot plot of hallmark pathways enriched or downregulated in MM54-treated WT mice (relative to PBS-treated controls) by GSEA. Comparisons are between MM54-treated and untreated from influenza infected mice, for endothelia and epithelia (two pairwise comparisons total). Dot size relates to statistical significance. All Data are representative of at least two independent experiments. Statistical analysis was performed using one-sided Wald test with Benjamini–Hochberg correction (a) or followed by Tukey’s post-test (b), or unpaired two-tailed Student’s t test (e). NES were generated with GSEA using a two-sided Kolmogorov Smirnov statistic with Hallmark genesets on genelists ranked by the Wald t statistic from DESeq2 (f) and significant P values are indicated on the graphs. Data are shown as mean±SEM. ns, not significant.

Source data

Extended Data Fig. 9 Dietary AHR ligands do not disrupt pulmonary inflammation.

a, Immune cell numbers were determined in the whole lung of WT mice fed purified or I3C-enriched diet on day 6 post infection by flow cytometry (n = 4). b, BALF IFN (day 2) and cytokine (day 6) concentrations in WT mice fed purified or I3C-enriched diet (n = 5). Statistical analysis was performed using unpaired two-tailed Student’s t test and significant P values are indicated on the graphs. Data are shown as mean±SEM. ns, not significant.

Source data

Supplementary information

Source data

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Major, J., Crotta, S., Finsterbusch, K. et al. Endothelial AHR activity prevents lung barrier disruption in viral infection. Nature 621, 813–820 (2023). https://doi.org/10.1038/s41586-023-06287-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41586-023-06287-y

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing